Atanackovic et al. found a 5-fold higher TGF-β level in MPEs in patients suffering from breast, esophageal, and pancreatic cancer and sarcoma compared to nonmalignant PEs. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.